Bioasis Technologies Inc.
BIOAF · OTC
2/28/2022 | 2/28/2021 | 2/28/2020 | 2/28/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $4 | $1 | $1 |
| % Growth | -99.1% | 572.5% | -57.4% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | -$1 | $3 | $1 | $1 |
| % Margin | -3,150.2% | 69.6% | 100% | 99.3% |
| R&D Expenses | $1 | $1 | $2 | $2 |
| G&A Expenses | $2 | $2 | $3 | $4 |
| SG&A Expenses | $2 | $2 | $3 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $4 | $5 | $6 |
| Operating Income | -$5 | -$1 | -$5 | -$6 |
| % Margin | -12,784.5% | -21% | -856.5% | -438.7% |
| Other Income/Exp. Net | $2 | $2 | $1 | $1 |
| Pre-Tax Income | -$3 | $1 | -$4 | -$3 |
| Tax Expense | $0 | $0 | $0 | -$1 |
| Net Income | -$3 | $1 | -$4 | -$3 |
| % Margin | -7,846.5% | 17.1% | -669% | -244.3% |
| EPS | -0.041 | 0.01 | -0.065 | -0.061 |
| % Growth | -498.1% | 115.8% | -6.2% | – |
| EPS Diluted | -0.041 | 0.01 | -0.065 | -0.061 |
| Weighted Avg Shares Out | 72 | 68 | 62 | 57 |
| Weighted Avg Shares Out Dil | 72 | 68 | 62 | 57 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | $0 | -$5 | -$5 |
| % Margin | -9,388.6% | 10.7% | -748% | -336.8% |